The FDA’s Evolving Regulatory Landscape

On July 23, Skadden hosted the webinar “The FDA’s Evolving Regulatory Landscape: How Makary-Era Policies Are Impacting the Industry.” The program explored how significant policy shifts emerging from FDA Commissioner Marty Makary’s tenure are affecting pharmaceutical and life sciences companies, particularly changes enacted outside the formal notice-and-comment rulemaking process. The discussion also covered recent FDA policy developments and HHS leadership changes and their impact on the pharmaceutical industry. Washington, D.C. FDA regulatory of counsel Rachel Turow presented.